Drug Profile
Stromal cell-derived factor-1
Alternative Names: SDF-1Latest Information Update: 14 Oct 2021
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical; Wyeth
- Class CXC chemokines
- Mechanism of Action Angiogenesis inducing agents; CXCR4 receptor agonists; Leukocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 05 Oct 2006 Discontinued - Preclinical for HIV infections treatment in Japan (unspecified route)
- 05 Oct 2006 Discontinued - Preclinical for HIV infections treatment in USA (unspecified route)
- 29 Jan 2003 Genetics Institute is now called Wyeth